Article Per Year (5 Year)
p-Index From 2021 - 2026
0.92
P-Index
This Author published in this journals
All Journal Jurnal Administrasi Kesehatan Indonesia PUBLIKASI PENELITIAN TERAPAN DAN KEBIJAKAN Narra J
Ekowati Retnaningsih
Badan Penelitian dan Pengembangan Daerah Provinsi Sumatera Selatan, Palembang
Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Economics, Econometrics & Finance Environmental Science Health Professions Immunology & microbiology Medicine & Pharmacology Public Health Social Sciences

Published : 22 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 22 Documents
Search

 1   2   3 
Implementasi Kemitraan Triple Helix pada Sistem Informasi Pemantauan Covid 19 di Sumatera Selatan: SiPantau Covid-19 Retnaningsih, Ekowati; Irwan, Irwan; Nuryanto, Nuryanto; Juairiyah, Oktaf; Oktarina, Reni; Komalasari, Oom
Publikasi Penelitian Terapan dan Kebijakan Vol 8 No 2 (2025): Publikasi Penelitian Terapan dan Kebijakan
Publisher : Badan Penelitian dan Pengembangan Daerah Provinsi Sumatera Selatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46774/pptk.v8i2.679

Abstract

The COVID-19 pandemic, which began in 2020, led to a surge in confirmed cases in Indonesia, reaching 4.2 million by the end of 2021. Transmission occurred largely through the mobility of travelers from high-risk areas to other regions. At that time, Indonesia lacked a digital system to monitor population mobility, and manual tracking methods effectively posed health risks. To address this challenge, the Research and Development Agency of South Sumatra Province initiated applied research to develop a COVID-19 monitoring information system based on a triple helix partnership model (academia, government, and private sector). Using an operational research approach, the study identified key issues: rapid virus transmission, high mobility, absence of a digital monitoring system, and weak inter-actor coordination. Triple helix actors included MDP University, Balitbangda, travelers, transport operators, community leaders, and government officials. Roles were distributed: academia developed the application, the government provided oversight and enforcement, and the public acted as users. The final product consisted of a mobile application for users and field officers, a web-based platform for the control room, and modules for related institutions. The system was piloted and implemented through a Governor's Decree. The triple helix partnership proved effective in developing the monitoring system
Comparison of anti-SARS-CoV-2 IgG seropositivity among vaccinated, unvaccinated, and COVID-19 survivor individuals: A cross-sectional study in Palembang, Indonesia Retnaningsih, Ekowati; Nuryanto, Nuryanto; Oktarina, Reni; Komalasari, Oom; Maryani, Sri; Larasti, Veny; Fertilita, Soilia
Narra J Vol. 5 No. 3 (2025): December 2025
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v5i3.2890

Abstract

Measurement of anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibody levels provides evidence of prior infection or vaccination. Persistent vaccine hesitancy underscores the importance of robust, evidence-based data to inform policy decisions. The aim of this study was to compare anti-SARS-CoV-2 IgG seropositivity among vaccinated individuals, unvaccinated individuals, and coronavirus disease 2019 (COVID-19) survivors in the community during the pandemic. In this cross-sectional study, 517 participants were enrolled, including 167 vaccinated individuals, 97 COVID-19 survivors, and 253 unvaccinated individuals, selected through multistage cluster sampling of 40 clusters. Anti-SARS-CoV-2 IgG seropositivity was defined as ≥50 AU/mL. Multivariable logistic regression was performed to evaluate associations between group type and seropositivity, adjusting for demographic factors, COVID-19 symptoms, hypertension, and body mass index (BMI). Vaccinated individuals demonstrated significantly higher odds of seropositivity compared with unvaccinated participants (odds ratio (OR)=5.60; 95% confidence interval (CI): 2.36–13.27). Covariates independently associated with seropositivity (p<0.05) included the presence of COVID-19 symptoms, hypertension, and BMI. Vaccination was strongly associated with increased anti-SARS-CoV-2 IgG seropositivity in the community, independent of clinical and demographic factors. These findings support ongoing vaccination campaigns and highlight the relevance of comorbidities and symptomatic history in shaping humoral immune responses.
Co-Authors Afrimelda, Afrimelda Fertilita, Soilia Irmitati, Irmitati Irwan Irwan Juairiyah, Oktaf Larasti, Veny Maryani, Sri Nila Mayang Sari, Nila Mayang Novitha, Irni Nuryanto Nuryanto Oktariza, Rini Oom Komalasari Pardomuan Robinson Sihombing Reni Oktarina Rusmiati, Rini Yesi, Desri Yulian Taviv Zulkarnaen, Muhammad